Day One Biopharmaceuticals, Inc (NASDAQ:DAWN) Shares Bought by Franklin Resources Inc theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report) has received a consensus rating of “Moderate Buy” from the seven research firms that are presently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12 […]
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN – Get Free Report) CEO Jeremy Bender sold 7,873 shares of the business’s stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $16.08, for a total transaction of $126,597.84. Following the completion of the sale, the chief executive officer now […]
FY2027 EPS Estimates for Day One Biopharmaceuticals, Inc (NASDAQ:DAWN) Lowered by Analyst theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
FY2027 EPS Estimates for Day One Biopharmaceuticals, Inc Cut by Wedbush (NASDAQ:DAWN) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.